Podcasts about recent advances

Featuring perspectives from Dr Christopher Lieu and Dr Kanwal Raghav, including the following topics: Optimizing the Care of Patients with Nonmetastatic Colorectal Cancer (CRC) — Dr Lieu (0:00) Recent Advances in the Management of Metastatic CRC — Dr Raghav (32:58) CME information and select publications

Featuring perspectives from Dr Rahul Aggarwal, Ms Monica Averia, Ms Kathleen D Burns and Dr William K Oh, including the following topics: Introduction: Overview of Prostate Cancer (0:00) Recent Advances in the Treatment of Nonmetastatic Prostate Cancer (8:36) Treatment Approaches for Metastatic Hormone-Sensitive Prostate Cancer (30:01) Current Role of PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer (mCRPC) (47:41) Current and Future Role of Radiopharmaceuticals in mCRPC (1:09:57) NCPD information and select publications

Krista Noonan, BSc, MD, FRCPC / Elizabeth R. Plimack, MD, MS, FASCO - Redefining the Standards of Care in RCC: Expert Insights to Translate Recent Advances to Clinical Practice

Krista Noonan, BSc, MD, FRCPC / Elizabeth R. Plimack, MD, MS, FASCO - Redefining the Standards of Care in RCC: Expert Insights to Translate Recent Advances to Clinical Practice

Hemophilia is a rare bleeding disorder caused by a deficiency in clotting factors in the blood, which can cause permanent damage to joints and, in some cases, life threatening bleeding, both externally and internally. Today, people with hemophilia can live generally long, healthy lives, but in previous generations, the future wasn't so bright. In fact, less than a century ago the life expectancy for someone with hemophilia hovered around just 10 years. It doesn't receive much attention, and when it does, what you hear might not be all that accurate. In today's episode, we cover the history of hemophilia and the science behind treatments over the decades, including the devastating impact of the HIV/AIDS epidemic on hemophilia patients. We'll also clear up several misconceptions, including one that seems to show up a lot in popular culture: that hemophilia is a "royal disease.” Send us your science facts, news, or other stories for a chance to be featured on an upcoming Tiny Show and Tell Us bonus episode. And, while you're at it, subscribe to our newsletter!Link to the Tiny Show & Tell stories are here and here. All Tiny Matters transcripts and references are available here.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Increased international travel has brought infectious diseases, once rarely encountered, into a broader setting. One such disease is Amoebiasis, which can be dangerous due to its possible presentation as inflammatory bowel disease. Deputy editor Dr. Aditi Kumar speaks with the authors of a recent paper on this subject, Dr. Joseph Cooney¹, Prof. Peter Chiodini² and Prof. Richard Pollok¹, titled "Recent advances in the diagnosis and management of amoebiasis"   1. Department of Gastroenterology, St George's University Hospitals NHS Foundation Trust, London, UK 2. Hospital for Tropical Diseases, London, London, UK   We hope you enjoy the #FGPodcast. Please follow @‌FrontGastro_BMJ. Listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify. If you enjoy our podcast, please rate us on your chosen platform, and leave us a review on the Frontline Gastroenterology Podcast page on iTunes: https://podcasts.apple.com/gb/podcast/fg-podcast/id942944229  

In this episode, host Alyssa Watson, DVM, welcomes Alyssa Jenkins, DVM, to talk about her recent Clinician's Brief article, “Top 3 Recent Advances in Feline Diabetes Management.” Dr. Jenkins starts with a feline diabetes mellitus refresher, including the comparison between it and type I/type II diabetes in humans. She then details the major new things for diabetic cats: SGLT2 inhibitors, longer-acting insulins, and continuous glucose monitors.Resource:https://www.cliniciansbrief.com/article/diabetes-cats-insulin-blood-sugar-monitorContact:podcast@instinct.vetWhere To Find Us:Website: CliniciansBrief.com/PodcastsYouTube: Youtube.com/@clinicians_briefFacebook: Facebook.com/CliniciansBriefLinkedIn: LinkedIn.com/showcase/CliniciansBrief/Instagram: @Clinicians.BriefX: @CliniciansBriefThe Team:Alyssa Watson, DVM - HostAlexis Ussery - Producer & Multimedia Specialist

“There is more awareness about who we are and what we do and the importance of the roles that we serve in our communities.” In this episode, listen to Dr. Heidi Hancher-Rauch and M. Elaine Auld share tips on best practices to advance the health education profession. Their commentary provides current and emerging health education researchers and practitioners with context and deliverables regarding where the profession has come from and where it is going. This episode references the article “The Coalition of National Health Education Organizations: Recent Advances to Strengthen the Health Education Profession” by Dr. Heidi Hancher-Rauch and M. Elaine Auld.

This episode is brought to you by Timeline Nutrition and Comrad Socks. What if enhancing your mitochondria could unlock a new level of vitality and longevity? In today's episode, Jen Scheinman, MS, RD, shares her insights on mitochondrial health and what the last decade of clinical evidence now shows us in the world of total human optimization. We take a deep dive into the intricate process of mitophagy and discuss the potent effects of urolithin A - a miracle discovery. Learn how this post biotic aids in revitalizing cellular function, leading to improved energy levels and endurance. Jen helps us understand the profound connection between mitochondrial support and overall well-being, offering us a pathway to a healthier, more vibrant life. Follow Jen @jenscheinman_nutrition Follow Timeline @timeline_longevity Follow Chase @chase_chewning ----- In this episode we discuss... (00:00) Recent Advances in Mitochondrial Health and Longevity (07:40) Exploring the Benefits of Fasting on General Health (17:37) Enhancing Performance and Endurance With Urolithin A (32:19) Optimizing Muscle Health and Performance (46:48) How to Dose Urolithin A for Optimal Results  (59:39) Maintaining Health and Resilience Over Time ----- Episode resources: Save 33% on your first order of MitoPure and improve cellular energy and muscle strength with code EVERFORWARD33 at https://www.Timeline.com/everforward33  Save 15% on gradual compression socks with code CHASEC15 at https://www.ComradSocks.com Watch and subscribe on YouTube Learn more at Timeline.com Episode 670 with Chris Rinsch 

On this episode, we will hear from integrative medical oncologist Dr. Ana Marie Lopez. Dr. Lopez will share exciting advances in cancer therapies including treatment de-escalation, new molecular treatments and the emerging research on the impact of diet and exercise in treatment responses.Five To Thrive Live is broadcast live Tuesdays at 7PM ET and Music on W4CS Radio – The Cancer Support Network (www.w4cy.com) part of Talk 4 Radio (www.talk4radio.com) on the Talk 4 Media Network (www.talk4media.com). Five To Thrive Live Podcast is also available on Talk 4 Media (www.talk4media.com), Talk 4 Podcasting (www.talk4podcasting.com), iHeartRadio, Amazon Music, Pandora, Spotify, Audible, and over 100 other podcast outlets.

In this episode, Christopher L. Bowlus, MD, discusses recent advances in the management of primary biliary cholangitis (PBC), including:Treatment goalsUse of PPAR agonists for the treatment of PBCClinical trial results for elafibranor (ELATIVE), seladelpar (RESPONSE), and bezafibrate (BEZURSO)Presenter:Christopher L. Bowlus, MDLena Valente Professor and ChiefDivision of Gastroenterology and HepatologyUniversity of California Davis School of MedicineSacramento, CaliforniaLink to full program: https://bit.ly/41tvSDuGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

In this episode, Christopher L. Bowlus, MD, discusses recent advances in the management of primary biliary cholangitis (PBC), including:Treatment goalsUse of PPAR agonists for the treatment of PBCClinical trial results for elafibranor (ELATIVE), seladelpar (RESPONSE), and bezafibrate (BEZURSO)Presenter:Christopher L. Bowlus, MDLena Valente Professor and ChiefDivision of Gastroenterology and HepatologyUniversity of California Davis School of MedicineSacramento, CaliforniaLink to full program: https://bit.ly/41tvSDuGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

Myocarditis - Presentation and Recent Advances   Guest: Drew Rosenbaum, M.D.  Host: Sharonne Hayes, M.D.   Through this podcast, listeners should understand how myocarditis manifests, both in the hospitalized patients as well as in clinical practice in order to facilitate recognition of the disease to initiate the appropriate work and achieve a diagnosis.  The treatment strategies depend highly on the underlying condition.  Although current strategies for treatment are evolving, a conceptual framework for which patients may benefit from anti-inflammatory therapies and which may not is critical to appropriate select therapies for patients affected by myocarditis.   Topics Discussed: What is the spectrum of manifestations of myocarditis? How do you diagnose myocarditis? How is myocarditis treated and what is on the horizon for myocarditis?   Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here.

Featuring slide presentations and related discussion from Dr Pasi A Jänne, Prof Tom John, Dr Zofia Piotrowska and Dr Alexander I Spira, including the following topics: Recent Advances in the Management of Localized and Locally Advanced Non-Small Cell Lung Cancer (NSCLC) with an EGFR Mutation — Prof John (0:00) First-Line Treatment for Advanced NSCLC with an EGFR Mutation — Dr Spira  (32:48) Later-Line Therapy for Advanced NSCLC with an EGFR Mutation — Dr Jänne (1:03:51) Management of NSCLC with an EGFR Exon 20 Mutation — Dr Piotrowska (1:33:33) CME information and select publications

Is the Paleo diet suitable for everyone? Despite the popularity of fad diets, you may be surprised at how to actually see results. Listen in to learn: The various diets popular right now Why intermittent fasting is especially effective Who can benefit most from a specific diet Robb Wolf, a former research biochemist and a two-time New York Times and WSJ Best Selling author, shares the latest dietary health and fitness info. Even though diets may be touted as widely effective, everyone functions differently and can benefit from more variability in the diet space. If a diet is not working for an individual, there may be underlying causes other than lack of discipline. For many of us, the most benefits can be found by combining many effective components of a range of diets. However, for one important takeaway, an emphasis on good-quality sleep and eating protein first in a meal are widely effective. Visit https://robbwolf.com to learn more. Episode also available on Apple Podcast: http://apple.co/30PvU9C

Featuring perspectives from Dr Scott Kopetz and Dr John Strickler, including the following topics: Introduction (0:00) Recent Therapeutic Advances in Colorectal Cancer (CRC) — Dr Strickler (1:53) New Developments in Targeted Therapy for Metastatic CRC — Dr Kopetz (35:11) CME information and select publications

Dr Scott Kopetz from The University of Texas MD Anderson Cancer Center in Houston, and Dr John Strickler from Duke University in Durham, North Carolina, discuss recent updates on available and novel treatment strategies for colorectal cancer.

Dr Scott Kopetz from The University of Texas MD Anderson Cancer Center in Houston, and Dr John Strickler from Duke University in Durham, North Carolina, discuss recent updates on available and novel treatment strategies for colorectal cancer.

Dr Scott Kopetz from The University of Texas MD Anderson Cancer Center in Houston, and Dr John Strickler from Duke University in Durham, North Carolina, discuss recent updates on available and novel treatment strategies for colorectal cancer.

Dr Scott Kopetz from The University of Texas MD Anderson Cancer Center in Houston, and Dr John Strickler from Duke University in Durham, North Carolina, discuss recent updates on available and novel treatment strategies for colorectal cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/ASCO2024/CRC).

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/RZJ865. CME/MOC/NCPD/AAPA/IPCE credit will be available until June 27, 2025.Navigating Recent Advances in Endometrial Carcinoma Treatment: Expert Guidance to Unleash the Power of Immunotherapy and Other Emerging Therapeutic Regimens In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by an independent medical education grant from GSK.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/RZJ865. CME/MOC/NCPD/AAPA/IPCE credit will be available until June 27, 2025.Navigating Recent Advances in Endometrial Carcinoma Treatment: Expert Guidance to Unleash the Power of Immunotherapy and Other Emerging Therapeutic Regimens In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by an independent medical education grant from GSK.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/RZJ865. CME/MOC/NCPD/AAPA/IPCE credit will be available until June 27, 2025.Navigating Recent Advances in Endometrial Carcinoma Treatment: Expert Guidance to Unleash the Power of Immunotherapy and Other Emerging Therapeutic Regimens In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by an independent medical education grant from GSK.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/RZJ865. CME/MOC/NCPD/AAPA/IPCE credit will be available until June 27, 2025.Navigating Recent Advances in Endometrial Carcinoma Treatment: Expert Guidance to Unleash the Power of Immunotherapy and Other Emerging Therapeutic Regimens In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by an independent medical education grant from GSK.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/RZJ865. CME/MOC/NCPD/AAPA/IPCE credit will be available until June 27, 2025.Navigating Recent Advances in Endometrial Carcinoma Treatment: Expert Guidance to Unleash the Power of Immunotherapy and Other Emerging Therapeutic Regimens In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by an independent medical education grant from GSK.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/RZJ865. CME/MOC/NCPD/AAPA/IPCE credit will be available until June 27, 2025.Navigating Recent Advances in Endometrial Carcinoma Treatment: Expert Guidance to Unleash the Power of Immunotherapy and Other Emerging Therapeutic Regimens In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by an independent medical education grant from GSK.Disclosure information is available at the beginning of the video presentation.

Featuring an interview with Dr Elias Jabbour, including the following topics: Evolution of research and therapeutic options for acute lymphoblastic leukemia (ALL) (0:00) Clinical and biological characteristics of ALL and implications for prognosis and disease management (6:36) Case: A 48-year-old woman with newly diagnosed Philadelphia chromosome-positive (Ph-positive) ALL attains complete remission with ponatinib/blinatumomab (14:03) Tolerability and improved quality of life with the chemotherapy-free combination of ponatinib and blinatumomab (24:17) Case: A 38-year-old man with newly diagnosed Ph-positive ALL experiences a complete molecular response with induction hyper-CVAD and ponatinib (27:10) CME information and select publications

Featuring a slide presentation and related discussion from Dr Elias Jabbour, including the following topics: Clinical management of Philadelphia chromosome-positive (Ph-positive) acute lymphoblastic leukemia (ALL); factors in the selection of initial induction  treatment (0:00) Primary and secondary endpoint outcomes from the Phase III PhALLCON trial comparing ponatinib to imatinib, each with reduced-intensity chemotherapy, as front-line treatment for Ph-positive ALL (5:22) Efficacy and tolerability of ponatinib in combination with blinatumomab for patients with newly diagnosed Ph-positive ALL (17:04) Ongoing research with novel agents and strategies for Ph-positive ALL (24:47) CME information and select publications

Dr Elias Jabbour from the University of Texas MD Anderson Cancer Center in Houston discusses recent advances in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.

Dr Elias Jabbour from the University of Texas MD Anderson Cancer Center in Houston discusses recent advances in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/OncologyTodayPHPosALL24).

“There is more awareness about who we are and what we do and the importance of the roles that we serve in our communities.” In this episode, listen to Dr. Heidi Hancher-Rauch and M. Elaine Auld share tips on best practices to advance the health education profession. Their commentary provides current and emerging health education researchers and practitioners with context and deliverables regarding where the profession has come from and where it is going. This episode references the article “The Coalition of National Health Education Organizations: Recent Advances to Strengthen the Health Education Profession” by Dr. Heidi Hancher-Rauch and M. Elaine Auld.

Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Herbert Tilg who is the Head of Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology & Metabolism, Medical University of Innsbruck, Innsbruck, Austria on on the Recent Advances in Clinical Practice paper "MASLD: a systemic metabolic disorder with cardiovascular and malignant complications" published in paper copy in Gut in April 2024. Read the paper: https://gut.bmj.com/content/73/4/691  Please subscribe to the Gut podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3UOTwqS) or Spotify (https://spoti.fi/3Ifxq9p). 

This week, join Simon on a deep dive through time into the evolution and possible origins of neurodiversity. From the ancient wisdom of neurodivergent shamans to the brilliant minds of Einstein, Darwin, and van Gogh, we'll uncover the hidden stories of how neurodiversity has been shaping our world in unexpected ways.But it's not all sunshine and rainbows. We'll also explore the dark side of how society has often misunderstood and marginalized those who think differently, and how the fight for neurodiversity acceptance is still an ongoing battle.1. Barack, D. L., Ludwig, V. U., Parodi, F., Ahmed, N., Brannon, E. M., Ramakrishnan, A., & Platt, M. L. (2024). Attention deficits linked with proclivity to explore while foraging. Proceedings of the Royal Society B: Biological Sciences, 291(1984), 20222584. https://doi.org/10.1098/rspb.2022.25842. Basaglia, F. (1987). The Man Who Closed the Asylums: Franco Basaglia and the Revolution in Mental Health Care. John Foot.3. Donald, M. (1991). Origins of the Modern Mind: Three Stages in the Evolution of Culture and Cognition. Harvard University Press.4. Eisenberg, D. T., Campbell, B., Gray, P. B., & Sorenson, M. D. (2008). Dopamine receptor genetic polymorphisms and body composition in undernourished pastoralists: An exploration of nutrition indices among nomadic and recently settled Ariaal men of northern Kenya. BMC Evolutionary Biology, 8(1), 173. https://doi.org/10.1186/1471-2148-8-1735. EurekAlert. (2021, April 7). ADHD and other disorders share the same cognitive deficits. https://www.eurekalert.org/news-releases/6480996. Feynman, R. P. (1985). "Surely You're Joking, Mr. Feynman!": Adventures of a Curious Character. W. W. Norton & Company.7. Foucault, M. (1988). Madness and Civilization: A History of Insanity in the Age of Reason. Vintage.8. Hacking, I. (1975). Why Does Language Matter to Philosophy? Cambridge University Press.9. Laing, R. D. (1967). The Politics of Experience and The Bird of Paradise. Penguin UK.10. Mashour, G. A., & Alkire, M. T. (2013). Evolution of Consciousness: Phylogeny, Ontogeny, and Emergence from General Anesthesia. Proceedings of the National Academy of Sciences, 110(Supplement 2), 10357-10364.11. New Atlas. (2023, March 10). Evolutionary benefits of ADHD illuminate why it's so common. https://newatlas.com/science/adhd-evolutionary-benefits-foraging-explore-exploit/13. Rogers, A., & Pilgrim, D. (2014). A Sociology of Mental Health and Illness. McGraw-Hill Education (UK).14. Silberman, S. (2015). NeuroTribes: The Legacy of Autism and the Future of Neurodiversity. Avery.15. Spikins, P. (2013). The Stone Age Origins of Autism. Recent Advances in Autism Spectrum Disorders - Volume II. InTech. http://dx.doi.org/10.5772/5388316. Temple Grandin's website: https://www.templegrandin.com/, various YouTube videos and articles.17. Thagard, P. (2013, May 21). When Did Consciousness Evolve?. Psychology Today. https://www.psychologytoday.com/us/blog/hot-thought/201305/when-did-consciousness-evolve18. The Art of Autism. (2020, November 28). Was Napoleon Bonaparte on the Autism Spectrum? https://the-art-of-autism.com/was-napoleon-bonaparAs ever we thank you, our loyal listeners for sticking with us. We would love to hear from you and our Twitter is open @AtypicalThePod for messages and comments. Have a topic you would like us to cover, or do you fancy joining us for a natter, maybe tell us about your area of interest or expertise and share these things with everyone. We would also recommend our friend The Autistic Women for another great view on living with autism and our friends at the All Bets are Off podcast who cover addiction.

This webinar will include live deliveries of two presentations from the recent FRTR Fall meeting, with updated information: "Best Practices for PFAS Sampling and Evaluation" "Clean Water Act Methods: Overview of EPA's CWA PFAS Method Activities". The science and technology of site characterization for per-and polyfluoroalkyl substances (PFAS) has advanced in the five years since FRTR last addressed the topic in 2018. Federal agency budgets for PFAS remediation have grown substantially during this time. As a result, site characterization efforts such as Remedial Investigations, as well as early response actions, are underway at many Federal facilities. Funding for field-scale projects to further advance PFAS characterization technology and methodologies also has increased substantially. This webinar will allow PFAS member agencies to share results of recent and on-going PFAS projects that are improving our understanding of PFAS characterization technologies. To view this archive online or download the slides associated with this seminar, please visit http://www.clu-in.org/conf/tio/FRTRFall23-BP-CWA_022824/

This webinar will include live deliveries of two presentations from the recent FRTR Fall meeting, with updated information: "Best Practices for PFAS Sampling and Evaluation" "Clean Water Act Methods: Overview of EPA's CWA PFAS Method Activities". The science and technology of site characterization for per-and polyfluoroalkyl substances (PFAS) has advanced in the five years since FRTR last addressed the topic in 2018. Federal agency budgets for PFAS remediation have grown substantially during this time. As a result, site characterization efforts such as Remedial Investigations, as well as early response actions, are underway at many Federal facilities. Funding for field-scale projects to further advance PFAS characterization technology and methodologies also has increased substantially. This webinar will allow PFAS member agencies to share results of recent and on-going PFAS projects that are improving our understanding of PFAS characterization technologies. To view this archive online or download the slides associated with this seminar, please visit http://www.clu-in.org/conf/tio/FRTRFall23-BP-CWA_022824/

In this episode, Cara and Missi review common vaginitis symptoms, evaluation, diagnosis, and treatment. They then dive deeper into complex presentations, recurrent infections, and treating mixed vaginitis. Vulvar and vaginal itching, irritation, discharge, and odor are a frequent reason for visits to a midwife or other GYN provider and this episode will build your confidence and competence in treating these issues. Resources for additional learning are provided.  #vaginitis #vulva #vagina #vaginaldischarge #selfcleaningoven #nodouching #boricacid #treatlocallyPowell A, Ghanem KG, Rogers L, et al. Clinicians' Use of Intravaginal Boric Acid Maintenance Therapy for Recurrent Vulvovaginal Candidiasis and Bacterial Vaginosis. Sex Transm Dis. 2019;46(12):810-812. doi:10.1097/OLQ.0000000000001063Qi W, Li H, Wang C, et al. Recent Advances in Presentation, Diagnosis and Treatment for Mixed Vaginitis. Front Cell Infect Microbiol. 2021;11:759795. Published 2021 Nov 2. doi:10.3389/fcimb.2021.759795

In an effort to protect us from getting killed by something we've ingested, our brain's vomit control center processes a lot of information from several different places … and sometimes is a little overly cautious.   LEARN MORE To learn more about this topic, start your googling with these keywords:  Emesis: The act of vomiting Vomiting: The oral eviction of gastrointestinal contents due to contractions in the gut and stomach. Nausea: A diffuse sensation of uneasiness and discomfort often felt as the need to vomit. Vomiting Center: An area in the brain's medulla oblongata that initiates and controls emesis. Chemoreceptor Trigger Zone: An area in the area postrema of the medulla oblongata that is sensitive to certain toxic chemicals in the blood.  Nucleus Tractus Solitarius: A region in the medulla oblongata that receives input from the cardiovascular, respiratory and GI systems.  Vagus Nerve: A cranial nerve that regulates internal organ functions, including vomiting.  Vestibular System: A Sensory system that provides our brain with information about motion, head position, and spatial positioning for balance. SUPPORT MINUTEEARTH If you like what we do, you can help us!: Become our patron:   Share this video with your friends and family Leave us a comment (we read them!)   CREDITS David Goldenberg | Script Writer, Narrator and Director Arcadi Garcia i Rius | Illustration, Video Editing and Animation  Nathaniel Schroeder | Music MinuteEarth is produced by Neptune Studios LLC      OUR STAFF Lizah van der Aart • Sarah Berman • Arcadi Garcia i Rius David Goldenberg • Melissa Hayes • Alex Reich  Henry Reich • Peter Reich • Ever Salazar Alexander Vidal • Leonardo Souza • Kate Yoshida   OUR LINKS Youtube | TikTok |   Twitter |   Instagram |   Facebook |   Website |   Apple Podcasts |    REFERENCES Singh P, Yoon SS, Kuo B. Nausea: a review of pathophysiology and therapeutics. Therap Adv Gastroenterol. 2016;9(1):98-112. Retrieved from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4699282/ Hasler, W. (2013). Pathology of emesis: its autonomic basis. Handbook of Clinical Neurology, Vol. 117 (3rd series) Autonomic Nervous System. Retrieved from: https://pubmed.ncbi.nlm.nih.gov/24095137/ Zhong W, Shahbaz O, Teskey G, Beever A, Kachour N, Venketaraman V, Darmani NA. Mechanisms of Nausea and Vomiting: Current Knowledge and Recent Advances in Intracellular Emetic Signaling Systems. Int J Mol Sci. 2021 May 28;22(11):5797. Retrieved from: https://pubmed.ncbi.nlm.nih.gov/34071460/ Kowalski A, Rapps N, Enck P. Functional cortical imaging of nausea and vomiting: a possible approach. Auton Neurosci. 2006 Oct 30;129(1-2):28-35. Retrieved from: https://pubmed.ncbi.nlm.nih.gov/16945593/ Hornby, PJ. Central neurocircuitry associated with emesis. Am J Med. 2001 Dec 3;111 Suppl 8A:106S-112S. Retrieved from: https://pubmed.ncbi.nlm.nih.gov/11749934/ Kuo, Braden. (2022). Personal Communication. Director of the Center for Neurointestinal Health at Mass General. https://www.massgeneral.org/doctors/17189/brad-kuo

In this episode of The Crop Science Podcast Show, our special guest is Dr. Scott Shearer, a leader in agricultural engineering. Dr. Shearer explores the transformative role of automation in agriculture, discussing the latest advancements in machinery control, autonomous vehicles, and the impact of AI on farming practices. Join us for this enlightening conversation that explores the forefront of agricultural technology and its implications for the future of farming."A tremendous amount of technology can be brought to bear on a lot of those traditionally problematic type areas. Combining adjustments has changed markedly. We see a lot cleaner grain samples, and a lot less grain on the ground as a result of this." - Dr. Scott ShearerWhat you'll learn:(00:00) Highlight(00:42) Introduction(03:41) Recent Advances in Agricultural Automation(07:27) Precision Planting on Agriculture(16:17) Future of Agricultural Automation(22:16) Impact of Tractor Ballasting on Compaction(28:03) Speed and Efficiency in Agricultural Machinery(37:55) End of the episodeMeet the guest: Dr. Scott Shearer, with his Ph.D. from The Ohio State University, is an expert in agricultural engineering. His work focuses on developing methods for precision agriculture and advancing autonomous machinery in farming. His passion for AI in agriculture and his significant contributions make him a notable figure in the crop science community.The Crop Science Podcast Show is trusted and supported by innovative companies like:- KWSAre you ready to unleash the podcasting potential of your company? wisenetix.co/custom-podcast

Embracing Changes: New Years Changes to Improve Your Wellbeing. Learn about how to embrace changes for the New Year and improve your wellbeing. We also discuss popular trends in food, wellness and other interesting things for 2024. Embracing changes can help improve your autoimmune healing. Dr. Christiane Schroeter, Accountability Coach Christiane started her Hello Happy Nest coaching business in 2013. She has degrees in Foods & Nutrition and a Ph.D. in Health Economics and 20+ years of experience helping solopreneurs transform their daily business & wellness routines. Christiane has worked as a professor for 15+ years and earned multiple national and international teaching and publication awards. Most of her clients find Christiane through her Happy Healthy Hustle Podcast, which is ranked among the TOP 1.5% globally. Christiane creates a community on Instagram, Facebook, and YouTube, sharing how to nurture your health without the overwhelm. Happy Healthy Hustle is a 1.5% global-ranked podcast- nurture your health to elevate wealth. Website: hellohappynest.com Email: info@hellohappynest.com Podcast: https://hellohappynest.com/podcast/ Instagram: https://www.instagram.com/hello.happy.nest/ YouTube: https://www.youtube.com/@hellohappynest Facebook: https://www.facebook.com/HelloHappyNest LinkedIn: https://www.linkedin.com/in/christianeschroeter/ TikTok https://www.tiktok.com/@hello.happy.nest?_t=8hBBs04caM Website for this podcast: http://autoimmunerehab.com Research Articles:  Embracing Change- https://www.nature.com/articles/s41684-019-0441-4 Emerging Food Trends- https://www.tandfonline.com/doi/abs/10.1080/10408398.2022.2106472 Recent Advances and Future Trends- https://www.sciencedirect.com/science/article/abs/pii/S0924224424000207  

This first episode in a 3-part series tackles the role of HER3 in cancer, specifically in NSCLC, and how HER3 can be effectively targeted with ADCs.Presenters in this series include:Rebecca S. Heist, MD, MPHAssociate Professor of MedicineHarvard Medical SchoolMedical OncologyMassachusetts General HospitalBoston, MassachusettsHelena Yu, MDAssociate AttendingDepartment of MedicineMemorial Sloan Kettering Cancer CenterNew York, New YorkSupported by an educational grant from Daiichi Sankyo, Inc. Link to full program, including a downloadable highlights slideset:https://bit.ly/48ecElW

This webinar will introduce some recent advances in consideration of ecosystem services in contaminated site cleanups. The team will introduce concepts, tools, and example applications. Then the audience will be shown how to find newly available resources and places to turn to for consideration of ecosystem services in their cleanup efforts. To view this archive online or download the slides associated with this seminar, please visit http://www.clu-in.org/conf/tio/Advances-Ecosystem-Services_083123/

This webinar will introduce some recent advances in consideration of ecosystem services in contaminated site cleanups. The team will introduce concepts, tools, and example applications. Then the audience will be shown how to find newly available resources and places to turn to for consideration of ecosystem services in their cleanup efforts. To view this archive online or download the slides associated with this seminar, please visit http://www.clu-in.org/conf/tio/Advances-Ecosystem-Services_083123/

Featuring perspectives from Dr Matthew D Galsky, Prof Andrea Necchi and Dr Scott T Tagawa, including the following topics: Current and Future Management of Nonmetastatic Urothelial Bladder Cancer (UBC) Introduction (0:00) Management of non-muscle-invasive bladder cancer (5:30) Neoadjuvant and adjuvant therapy for muscle-invasive bladder cancer (18:39) Management of nonmetastatic UBC in patients who are not candidates for cystectomy (27:55) Recent Advances in the Treatment of Metastatic UBC (mUBC) Selection and sequencing of therapy for platinum-eligible patients with FGFR wild-type mUBC (31:03) Selection and sequencing of therapy for platinum-ineligible patients with FGFR wild-type mUBC (41:26) Selection and sequencing of therapy for patients with FGFR-altered mUBC (45:07) Novel agents and strategies under investigation in UBC (53:53) CME information and select publications

Featuring perspectives from Dr Komal Jhaveri, Dr Kevin Kalinsky, Dr Ian E Krop, Dr Joyce O'Shaughnessy, Dr Hope S Rugo and Prof Peter Schmid, including the following topics: Long-Term Management of HER2-Positive Breast Cancer Introduction (0:00) Management of CNS-only disease progression in patients with HER2-positive metastatic breast cancer (2:27) Synergy between tucatinib and HER2-targeted antibody-drug conjugates (5:24) Management of trastuzumab deruxtecan–related adverse events (7:41) Patient selection for and practical implementation of postadjuvant neratinib (13:23) Faculty presentation: Dr Krop (16:26) Optimizing the Management of ER-Positive Localized Breast Cancer Ovarian function suppression to preserve fertility and prevent premature ovarian insufficiency; interrupting adjuvant hormonal therapy to attempt pregnancy (24:56) Selection of patients for adjuvant tamoxifen monotherapy (29:05) Utility of genomic assays in the neoadjuvant setting; management of node-positive disease in postmenopausal patients with low-risk Recurrence Scores® (33:35) Selection between abemaciclib and ribociclib in the adjuvant setting (36:45) Potential utility of circulating tumor DNA assessment in breast cancer (41:58) Faculty presentation: Dr Kalinsky (46:36) Considerations in the Care of Patients with ER-Positive Metastatic Breast Cancer Preference of CDK4/6 inhibitor in the metastatic setting (56:42) Sequencing of trastuzumab deruxtecan in ER-positive, HER2-low metastatic breast cancer (59:00) Faculty presentation: Dr Jhaveri (1:06:39) Novel and Emerging Strategies for ER-Positive Metastatic Breast Cancer Selection of therapy for ER-positive metastatic breast cancer progressing on a CDK4/6 inhibitor; future role of capivasertib (1:19:31) Faculty presentation: Dr Rugo (1:30:39) Evolving Clinical Decision-Making for Localized Triple-Negative Breast Cancer (TNBC) Management of localized TNBC; selection of patients for adjuvant Olaparib (1:46:10) PARP inhibitor tolerability (1:51:55) Faculty presentation: Dr O'Shaughnessy (1:55:31) Recent Advances in the Treatment of Metastatic TNBC (mTNBC) Selection of therapy for triple-negative metastatic breast cancer; sequencing of trastuzumab deruxtecan in ER-negative, HER2-low disease (2:11:08) Faculty presentation: Prof Schmid (2:18:03) CME information and select publications

Welcome to “Analytically Speaking,” the podcast from LCGC and Spectroscopy. Here in Episode 13, podcast host Dr. Jerry Workman talks to Dr. Paul C. DeRose, who is a senior research chemist at the National Institute of Standards and Technology (NIST) and leads the NIST Biochemical Science Division's project in luminescence standards development for chemical analysis and assay validation. We spoke to Paul about his current research interests in fluorescence and luminescence spectroscopy, specifically concerning the development of fluorescence standards and methods for validation of chemical and clinical assays. Paul's research has resulted in publications in various areas of fluorescence spectroscopy and microscopy. He has developed fluorescence standard guidelines and recommendations for ASTM, IUPAC, and the US Pharmacopeia. He is also the chair of ASTM E13.01.01 sub-committee on Molecular Luminescence.

In 2021, the estimated number of women in the United States living with metastatic breast cancer rose to about 168,000 from 155,000 the year before, according to the Breast Cancer Research Foundation. The good news is that survival rates are also climbing, Over the last 20 years, advances in HER2 targeting treatments, ADCs, immune checkpoint inhibitors, and CDK4/6 inhibitors have prolonged survival and changed the breast cancer treatment landscape. New treatment paradigms and advances invariably lead to more questions about optimal drug sequencing, mechanisms of resistance, and how to overcome that resistanceIn this episode we attempt to tackle these questions and review new advances and trends in MBC with assistance from Dr. Stephanie GraffTake a listen. It is going to be an exciting discussion.More info about the show and past episodes is available on our website: www.ourmbclife.orgGot something to share? Feedback? Email: ourmbclife@sharecancersupport.orgFollow us on Facebook, Instagram, and twitter @ourmbclif

Proceedings from a daylong symposium hosted in partnership with North Carolina Oncology Association and the South Carolina Oncology Society, featuring key clinical presentations and papers in breast cancer, gastrointestinal cancers, genitourinary cancers, chronic lymphocytic leukemia and lymphomas, gynecologic cancers and lung cancer. Featuring perspectives from Drs Tanios Bekaii-Saab, Michael Birrer, Danielle Brander, Harold Burstein, Ibiayi Dagogo-Jack, Virginia Kaklamani, Stephen Liu, Ursula Matulonis, Rutika Mehta, Craig Moskowitz, Daniel Petrylak and Sandy Srinivas.

Proceedings from a daylong symposium hosted in partnership with North Carolina Oncology Association and the South Carolina Oncology Society, featuring key clinical presentations and papers in breast cancer, gastrointestinal cancers, genitourinary cancers, chronic lymphocytic leukemia and lymphomas, gynecologic cancers and lung cancer. Featuring perspectives from Drs Tanios Bekaii-Saab, Michael Birrer, Danielle Brander, Harold Burstein, Ibiayi Dagogo-Jack, Virginia Kaklamani, Stephen Liu, Ursula Matulonis, Rutika Mehta, Craig Moskowitz, Daniel Petrylak and Sandy Srinivas.

This week on Seizing Life® we take a look at diagnostic and surgical tools that assist physicians in localizing and removing areas of the brain that produce seizures. In an episode recorded this past November at Epilepsy Awareness Day at Disneyland, Kelly speaks with several exhibitors to learn more about current and emerging technology that is helping to improve the lives of those with epilepsy. The post Recent Advances in Diagnostic and Surgical Tools for Epilepsy appeared first on CURE Epilepsy.

This week on Seizing Life® we look at diagnostic and surgical tools that assist physicians in localizing and removing areas of the brain that produce seizures. The post Recent Advances in Diagnostic and Surgical Tools for Epilepsy appeared first on CURE Epilepsy.